{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:05:18Z","timestamp":1778940318579,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07977","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T10:03:23Z","timestamp":1422007403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diminished serum repetin levels in patients with schizophrenia and bipolar disorder"],"prefix":"10.1038","volume":"5","author":[{"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuiping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shucheng","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bomiao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan Will","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"BFsrep07977_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/bmj.327.7416.632","volume":"327","author":"A Sawa","year":"2003","unstructured":"Sawa, A. & Kamiya, A. Elucidating the pathogenesis of schizophrenia. Bmj 327, 632\u2013633 (2003).","journal-title":"Bmj"},{"key":"BFsrep07977_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(09)60072-6","volume":"373","author":"P Lichtenstein","year":"2009","unstructured":"Lichtenstein, P. et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234\u2013239 (2009).","journal-title":"Lancet"},{"key":"BFsrep07977_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/ng.2742","volume":"45","author":"S Ripke","year":"2013","unstructured":"Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45, 1150\u20131159 (2013).","journal-title":"Nat Genet"},{"key":"BFsrep07977_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-014-1806-z","volume":"357","author":"MJ Berridge","year":"2014","unstructured":"Berridge, M. J. Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res 357, 477\u2013492 (2014).","journal-title":"Cell Tissue Res"},{"key":"BFsrep07977_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/mp.2013.152","volume":"19","author":"JR Glausier","year":"2014","unstructured":"Glausier, J. R., Fish, K. N. & Lewis, D. A. Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry 19, 30\u201336 (2014).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.schres.2014.05.005","volume":"157","author":"AM Boley","year":"2014","unstructured":"Boley, A. M., Perez, S. M. & Lodge, D. J. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia. Schizophr Res 157, 238\u2013243 (2014).","journal-title":"Schizophr Res"},{"key":"BFsrep07977_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-011-0881-4","volume":"122","author":"AY Wang","year":"2011","unstructured":"Wang, A. Y. et al. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol 122, 615\u2013626 (2011).","journal-title":"Acta Neuropathol"},{"key":"BFsrep07977_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.schres.2011.06.007","volume":"131","author":"C Konradi","year":"2011","unstructured":"Konradi, C. et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131, 165\u2013173 (2011).","journal-title":"Schizophr Res"},{"key":"BFsrep07977_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/pcn.12024","volume":"67","author":"S Yelmo-Cruz","year":"2013","unstructured":"Yelmo-Cruz, S., Morera-Fumero, A. L. & Abreu-Gonzalez, P. S100B and schizophrenia. Psychiatry Clin Neurosci 67, 67\u201375 (2013).","journal-title":"Psychiatry Clin Neurosci"},{"key":"BFsrep07977_CR10","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jpsychires.2013.07.005","volume":"47","author":"T Gos","year":"2013","unstructured":"Gos, T. et al. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. J Psychiatr Res 47, 1694\u20131699 (2013).","journal-title":"J Psychiatr Res"},{"key":"BFsrep07977_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/sj.mp.4001548","volume":"9","author":"M Rothermundt","year":"2004","unstructured":"Rothermundt, M. et al. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9, 897\u2013899 (2004).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.mp.4001974","volume":"12","author":"JC Lambert","year":"2007","unstructured":"Lambert, J. C. et al. Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly. Mol Psychiatry 12, 870\u2013880 (2007).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/mp.2008.85","volume":"14","author":"ML Schroeter","year":"2009","unstructured":"Schroeter, M. L. & Steiner, J. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol Psychiatry 14, 235\u2013237 (2009).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1515\/CCLM.2011.083","volume":"49","author":"J Steiner","year":"2011","unstructured":"Steiner, J., Bogerts, B., Schroeter, M. L. & Bernstein, H. G. S100B protein in neurodegenerative disorders. Clin Chem Lab Med 49, 409\u2013424 (2011).","journal-title":"Clin Chem Lab Med"},{"key":"BFsrep07977_CR15","doi-asserted-by":"publisher","first-page":"e82535","DOI":"10.1371\/journal.pone.0082535","volume":"8","author":"C van der Leeuw","year":"2013","unstructured":"van der Leeuw, C. et al. Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorder. PLoS One 8, e82535 (2013).","journal-title":"PLoS One"},{"key":"BFsrep07977_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/geno.1997.4818","volume":"43","author":"P Krieg","year":"1997","unstructured":"Krieg, P. et al. Repetin (Rptn), a new member of the \"fused gene\" subgroup within the S100 gene family encoding a murine epidermal differentiation protein. Genomics 43, 339\u2013348 (1997).","journal-title":"Genomics"},{"key":"BFsrep07977_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.0022-202X.2005.23675.x","volume":"124","author":"M Huber","year":"2005","unstructured":"Huber, M. et al. Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. J Invest Dermatol 124, 998\u20131007 (2005).","journal-title":"J Invest Dermatol"},{"key":"BFsrep07977_CR18","doi-asserted-by":"crossref","unstructured":"Nollet, M., Le Guisquet, A. M. & Belzung, C. Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol Chapter 5, Unit 5 65 (2013).","DOI":"10.1002\/0471141755.ph0565s61"},{"key":"BFsrep07977_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbr.2014.08.040","volume":"275C","author":"H Qiao","year":"2014","unstructured":"Qiao, H., An, S. C., Ren, W. & Ma, X. M. Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression. Behav Brain Res 275C, 191\u2013200 (2014).","journal-title":"Behav Brain Res"},{"key":"BFsrep07977_CR20","doi-asserted-by":"publisher","first-page":"e39084","DOI":"10.1371\/journal.pone.0039084","volume":"7","author":"S Imai","year":"2012","unstructured":"Imai, S. et al. Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system. PLoS One 7, e39084 (2012).","journal-title":"PLoS One"},{"key":"BFsrep07977_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan, J. F. & Mombereau, C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9, 326\u2013357 (2004).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR22","doi-asserted-by":"publisher","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","volume":"6","author":"J Ferno","year":"2011","unstructured":"Ferno, J. et al. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One 6, e20571 (2011).","journal-title":"PLoS One"},{"key":"BFsrep07977_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4161\/cam.3.1.7401","volume":"3","author":"J He","year":"2009","unstructured":"He, J., Kong, J., Tan, Q. R. & Li, X. M. Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. Cell Adh Migr 3, 129\u2013137 (2009).","journal-title":"Cell Adh Migr"},{"key":"BFsrep07977_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/aps.2011.77","volume":"32","author":"JN Picada","year":"2011","unstructured":"Picada, J. N. et al. Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol Sin 32, 1225\u20131232 (2011).","journal-title":"Acta Pharmacol Sin"},{"key":"BFsrep07977_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.06.027","volume":"142","author":"RP Vertes","year":"2006","unstructured":"Vertes, R. P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 142, 1\u201320 (2006).","journal-title":"Neuroscience"},{"key":"BFsrep07977_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0920-9964(02)00383-3","volume":"62","author":"ML Schroeter","year":"2003","unstructured":"Schroeter, M. L. et al. Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia. Schizophr Res 62, 231\u2013236 (2003).","journal-title":"Schizophr Res"},{"key":"BFsrep07977_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/archgenpsychiatry.2012.704","volume":"69","author":"P Roussos","year":"2012","unstructured":"Roussos, P., Katsel, P., Davis, K. L., Siever, L. J. & Haroutunian, V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry 69, 1205\u20131213 (2012).","journal-title":"Arch Gen Psychiatry"},{"key":"BFsrep07977_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archgenpsychiatry.2011.43","volume":"68","author":"M Focking","year":"2011","unstructured":"Focking, M. et al. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry 68, 477\u2013488 (2011).","journal-title":"Arch Gen Psychiatry"},{"key":"BFsrep07977_CR29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/mp.2013.30","volume":"19","author":"AL Guillozet-Bongaarts","year":"2014","unstructured":"Guillozet-Bongaarts, A. L. et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 19, 478\u2013485 (2014).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1192\/bjp.172.6.527","volume":"172","author":"PJ Shah","year":"1998","unstructured":"Shah, P. J., Ebmeier, K. P., Glabus, M. F. & Goodwin, G. M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 172, 527\u2013532 (1998).","journal-title":"Br J Psychiatry"},{"key":"BFsrep07977_CR31","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1073\/pnas.93.9.3908","volume":"93","author":"YI Sheline","year":"1996","unstructured":"Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G. & Vannier, M. W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93, 3908\u20133913 (1996).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep07977_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pscychresns.2010.03.007","volume":"183","author":"K Zierhut","year":"2010","unstructured":"Zierhut, K. et al. The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Res 183, 187\u2013194 (2010).","journal-title":"Psychiatry Res"},{"key":"BFsrep07977_CR33","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1093\/brain\/awp098","volume":"132","author":"S Benetti","year":"2009","unstructured":"Benetti, S. et al. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain 132, 2426\u20132436 (2009).","journal-title":"Brain"},{"key":"BFsrep07977_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/YCO.0000000000000073","volume":"27","author":"HQ Sun","year":"2014","unstructured":"Sun, H. Q., Bao, Y. P., Zhou, S. J., Meng, S. Q. & Lu, L. The new pattern of drug abuse in China. Curr Opin Psychiatry 27, 251\u2013255 (2014).","journal-title":"Curr Opin Psychiatry"},{"key":"BFsrep07977_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1521-0391.2014.12090.x","volume":"23","author":"CY Fan","year":"2014","unstructured":"Fan, C. Y., Tan, H. K., Chien, I. C. & Chou, S. Y. Prevalence of psychiatric disorders among heroin users who received methadone maintenance therapy in Taiwan. Am J Addict 23, 249\u2013256 (2014).","journal-title":"Am J Addict"},{"key":"BFsrep07977_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/0269881107078491","volume":"21","author":"F Angelucci","year":"2007","unstructured":"Angelucci, F. et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol 21, 820\u2013825 (2007).","journal-title":"J Psychopharmacol"},{"key":"BFsrep07977_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fnhum.2014.00537","volume":"8","author":"JH Hsieh","year":"2014","unstructured":"Hsieh, J. H., Stein, D. J. & Howells, F. M. The neurobiology of methamphetamine induced psychosis. Front Hum Neurosci 8, 537 (2014).","journal-title":"Front Hum Neurosci"},{"key":"BFsrep07977_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K","volume":"35","author":"RB Rothman","year":"2000","unstructured":"Rothman, R. B. et al. Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse 35, 222\u2013227 (2000).","journal-title":"Synapse"},{"key":"BFsrep07977_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/293300a0","volume":"293","author":"MR Celio","year":"1981","unstructured":"Celio, M. R. & Heizmann, C. W. Calcium-binding protein parvalbumin as a neuronal marker. Nature 293, 300\u2013302 (1981).","journal-title":"Nature"},{"key":"BFsrep07977_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1440-1789.2007.00867.x","volume":"28","author":"T Sakai","year":"2008","unstructured":"Sakai, T. et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28, 143\u2013150 (2008).","journal-title":"Neuropathology"},{"key":"BFsrep07977_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.mp.4000889","volume":"6","author":"M Rothermundt","year":"2001","unstructured":"Rothermundt, M. et al. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 6, 445\u2013449 (2001).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.psychres.2008.01.002","volume":"167","author":"ML Schroeter","year":"2009","unstructured":"Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A. & Blasig, I. E. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia\u2013original research and meta-analysis. Psychiatry Res 167, 66\u201372 (2009).","journal-title":"Psychiatry Res"},{"key":"BFsrep07977_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/mp.2010.23","volume":"16","author":"S Kim","year":"2011","unstructured":"Kim, S. & Webster, M. J. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 16, 452\u2013461 (2011).","journal-title":"Mol Psychiatry"},{"key":"BFsrep07977_CR44","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.mehy.2013.03.026","volume":"80","author":"SG Ewing","year":"2013","unstructured":"Ewing, S. G. & Winter, C. The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia. Med Hypotheses 80, 827\u2013832 (2013).","journal-title":"Med Hypotheses"},{"key":"BFsrep07977_CR45","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1176\/appi.ajp.161.11.2138-a","volume":"161","author":"S Heckers","year":"2004","unstructured":"Heckers, S. The hippocampus in schizophrenia. Am J Psychiatry 161, 2138\u20132139 (2004).","journal-title":"Am J Psychiatry"},{"key":"BFsrep07977_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.schres.2007.04.016","volume":"94","author":"B Porton","year":"2007","unstructured":"Porton, B. & Wetsel, W. C. Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia. Schizophr Res 94, 366\u2013370 (2007).","journal-title":"Schizophr Res"},{"key":"BFsrep07977_CR47","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1038\/tp.2013.94","volume":"3","author":"Y Hwang","year":"2013","unstructured":"Hwang, Y. et al. Gene expression profiling by mRNA sequencing reveals increased expression of immune\/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry 3, e321 (2013).","journal-title":"Transl Psychiatry"},{"key":"BFsrep07977_CR48","doi-asserted-by":"publisher","first-page":"C50","DOI":"10.1152\/ajpcell.1983.244.1.C50","volume":"244","author":"JH Pavlovitch","year":"1983","unstructured":"Pavlovitch, J. H., Didierjean, L., Rizk, M., Balsan, S. & Saurat, J. H. Skin calcium-binding protein: distribution in other tissues. Am J Physiol 244, C50\u201357 (1983).","journal-title":"Am J Physiol"},{"key":"BFsrep07977_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/schbul\/5.4.623","volume":"5","author":"DO Rudin","year":"1979","unstructured":"Rudin, D. O. Covert transport dysfunction in the choroid plexus as a possible cause of schizophrenia. Schizophr Bull 5, 623\u2013626 (1979).","journal-title":"Schizophr Bull"},{"key":"BFsrep07977_CR50","first-page":"365","volume":"54","author":"I Marinescu","year":"2013","unstructured":"Marinescu, I., Udristoiu, I. & Marinescu, D. Choroid plexus calcification: clinical, neuroimaging and histopathological correlations in schizophrenia. Rom J Morphol Embryol 54, 365\u2013369 (2013).","journal-title":"Rom J Morphol Embryol"},{"key":"BFsrep07977_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/00207459309000595","volume":"71","author":"R Sandyk","year":"1993","unstructured":"Sandyk, R. Choroid plexus calcification as a possible marker of hallucinations in schizophrenia. Int J Neurosci 71, 87\u201392 (1993).","journal-title":"Int J Neurosci"},{"key":"BFsrep07977_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0920-9964(90)90024-2","volume":"3","author":"R Sandyk","year":"1990","unstructured":"Sandyk, R., Kay, S. R. & Merriam, A. E. Calcification of the choroid plexus as a marker of depression in schizophrenia. Schizophr Res 3, 361\u2013363 (1990).","journal-title":"Schizophr Res"},{"key":"BFsrep07977_CR53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0304-3940(98)00935-5","volume":"259","author":"G Bersani","year":"1999","unstructured":"Bersani, G., Garavini, A., Taddei, I., Tanfani, G. & Pancheri, P. Choroid plexus calcification as a possible clue of serotonin implication in schizophrenia. Neurosci Lett 259, 169\u2013172 (1999).","journal-title":"Neurosci Lett"},{"key":"BFsrep07977_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1083\/jcb.151.2.389","volume":"151","author":"PJ Koch","year":"2000","unstructured":"Koch, P. J. et al. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 151, 389\u2013400 (2000).","journal-title":"J Cell Biol"},{"key":"BFsrep07977_CR55","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/11926","volume":"22","author":"JA Segre","year":"1999","unstructured":"Segre, J. A., Bauer, C. & Fuchs, E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22, 356\u2013360 (1999).","journal-title":"Nat Genet"},{"key":"BFsrep07977_CR56","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1600-0447.1988.tb05189.x","volume":"77","author":"JB Lohr","year":"1988","unstructured":"Lohr, J. B. & Jeste, D. V. Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 77, 689\u2013697 (1988).","journal-title":"Acta Psychiatr Scand"},{"key":"BFsrep07977_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0165-1781(89)90006-1","volume":"27","author":"N Gay","year":"1989","unstructured":"Gay, N., Cottraux, J. A., Denoroy, L., Tommasi, M. & Kopp, N. Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study. Psychiatry Res 27, 31\u201338 (1989).","journal-title":"Psychiatry Res"},{"key":"BFsrep07977_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.biopsych.2008.03.021","volume":"64","author":"E Shibata","year":"2008","unstructured":"Shibata, E. et al. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 64, 401\u2013406 (2008).","journal-title":"Biol Psychiatry"},{"key":"BFsrep07977_CR59","first-page":"80","volume":"11","author":"M Ferrucci","year":"2013","unstructured":"Ferrucci, M., Giorgi, F. S., Bartalucci, A., Busceti, C. L. & Fornai, F. The effects of locus coeruleus and norepinephrine in methamphetamine toxicity. Curr Neuropharmacol 11, 80\u201394 (2013).","journal-title":"Curr Neuropharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07977","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:10:20Z","timestamp":1672953020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep07977"],"URL":"https:\/\/doi.org\/10.1038\/srep07977","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]},"assertion":[{"value":"3 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7977"}}